Showing results (931-940 of 1,206) with videos related to
Sort By:
Pageof 121
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 15, 2019
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trialNorihiro Kogame, Ply Chichareon, Kenneth De Wilder, et al.Journal of the American College of Cardiology|May 21, 2013
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilizationDarren Mylotte, Ruben L J Osnabrugge, Stephan Windecker, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 11, 2020
Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarctionHideyuki Kawashima, Hironori Hara, Rutao Wang, et al.European Journal of Heart Failure|March 30, 2023
Cardio-hepatic syndrome in patients undergoing mitral valve transcatheter edge-to-edge repairLukas Stolz, Mathias Orban, Nicole Karam, et al.Atherosclerosis|May 26, 2020
The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trialRutao Wang, Kuniaki Takahashi, Ply Chichareon, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.Circulation. Cardiovascular Interventions|January 6, 2011
Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.Cardiovascular Research|February 15, 2018
Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activityDaniel S Gaul, Julien Weber, Lambertus J van Tits, et al.JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.Pageof 121